RankingsPricing
  1. JP-listed companies
  2. Oncolys BioPharma Inc.
  3. Financials
  4. Operating income

Oncolys BioPharma Inc.【JP:4588】

Market cap
¥37.9B
P/E ratio
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Dec 31, 2024-1,681-12.88%
Dec 31, 2023-1,930+60.23%
Dec 31, 2022-1,205-17.19%
Dec 31, 2021-1,455-13.14%
Dec 31, 2020-1,675+227.42%
Dec 31, 2019-511-59.00%
Dec 31, 2018-1,248+15.69%
Dec 31, 2017-1,078+25.20%
Dec 31, 2016-861-9.49%
Dec 31, 2015-952+14.96%
Dec 31, 2014-828

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)